Literature DB >> 17024572

Consequences of living-donor liver transplantation for upper gastrointestinal lesions: high incidence of reflux esophagitis.

Tomotaka Akatsu1, Masashi Yoshida, Shigeyuki Kawachi, Minoru Tanabe, Motohide Shimazu, Koichiro Kumai, Masaki Kitajima.   

Abstract

There is little information available regarding the consequences of living-donor liver transplantation (LDLT) for upper gastrointestinal lesions. We retrospectively compared the pre- and posttransplant incidences of noninfectious reflux esophagitis, portal hypertensive gastropathy (PHG), esophageal varix, gastroduodenal ulcer, Helicobacter pylori infection, and abnormal gastroesophageal valve in 29 adult patients (16 males, 13 females) who underwent LDLT for end-stage liver disease. Here we present four findings from this study. First, the posttransplant incidence of noninfectious esophagitis was significantly higher than the pretransplant incidence (27.6% vs. 3.4%; P < 0.001), irrespective of postoperative use of standard-dose H2RA. Second, PHG and esophageal varix, which were noted in 65.5% and 96.6% of pretransplant recipients, respectively, spontaneously resolved postoperatively in all cases. Third, H. pylori infection, which was observed in 50.0% of preoperative recipients, decreased to 5.6% postoperatively, although no significant difference was observed between the pre- and the posttransplant incidences of gastroduodenal ulcer (6.9% vs. 6.9%). Finally, the incidence of abnormal gastroesophageal valve did not change following LDLT (34.5% vs. 34.5%). In conclusion, this study suggests that noninfectious reflux esophagitis occurs more frequently following LDLT. Although the disease is the results of a very complex interaction of various factors, spontaneous resolution of PHG and serendipitous H. pylori eradication might have contributed to increased incidence of postoperative esophagitis, possibly through gastric acid hypersecretion. In contrast, morphological change of the gastroesophageal valve was not considered to be the cause of this disease. Because this study was a retrospective analysis of a small population of LDLT recipients, prospective randomized controlled studies of a sufficient number of cases are required to substantiate these conclusions.

Entities:  

Mesh:

Year:  2006        PMID: 17024572     DOI: 10.1007/s10620-006-9362-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Modulation of acid secretion in common bile duct ligation-related gastropathy in Wistar rats.

Authors:  S Kaur; U Kaur; N Agnihotri; C D Tandon; S Majumdar
Journal:  J Gastroenterol Hepatol       Date:  2001-07       Impact factor: 4.029

2.  Portal hypertensive gastropathy in patients with cirrhosis.

Authors:  T Iwao; A Toyonaga; M Sumino; K Takagi; K Oho; M Nishizono; K Ohkubo; R Inoue; E Sasaki; K Tanikawa
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

3.  Increased waiting time for liver transplantation results in higher mortality.

Authors:  J E Everhart; M Lombardero; K M Detre; R K Zetterman; R H Wiesner; J R Lake; J H Hoofnagle
Journal:  Transplantation       Date:  1997-11-15       Impact factor: 4.939

4.  Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux.

Authors:  H J Stein; A P Barlow; T R DeMeester; R A Hinder
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

5.  Role of Helicobacter pylori in cirrhotic patients with dyspepsia: a 13C-urea breath test study.

Authors:  J L Yeh; Y C Peng; C F Tung; G H Chen; W K Chow; C S Chang; H Z Yeh; S K Poon
Journal:  Adv Ther       Date:  2001 May-Jun       Impact factor: 3.845

6.  The effects of Helicobacter pylori colonization on gastric function and the incidence of portal hypertensive gastropathy in patients with cirrhosis of the liver.

Authors:  K K Balan; A T Jones; N B Roberts; J P Pearson; M Critchley; S A Jenkins
Journal:  Am J Gastroenterol       Date:  1996-07       Impact factor: 10.864

7.  Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion.

Authors:  T Koike; S Ohara; H Sekine; K Iijima; Y Abe; K Kato; T Toyota; T Shimosegawa
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

8.  Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively.

Authors:  M Rabinovitz; Y K Yoo; R R Schade; V J Dindzans; D H Van Thiel; J S Gavaler
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

9.  Gastric acid hypersecretion in refractory gastroesophageal reflux disease.

Authors:  M J Collen; J H Lewis; S B Benjamin
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

10.  Frequency of upper gastrointestinal lesions in patients with liver cirrhosis.

Authors:  C Sacchetti; M Capello; P Rebecchi; L Roncucci; G Zanghieri; A Tripodi; M Ponz de Leon
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

View more
  10 in total

1.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

2.  Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemia.

Authors:  Song-Seng Loke; Kuender D Yang; Kuang-Den Chen; Jung-Fu Chen
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 3.  Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1.

Authors:  Sharad Sharma; Ahmet Gurakar; Nicolas Jabbour
Journal:  Dig Dis Sci       Date:  2007-11-09       Impact factor: 3.199

4.  Biliary and vascular anomalies in living liver donors: the role and accuracy of pre-operative radiological mapping.

Authors:  Maja Segedi; Andrzej K Buczkowski; Charles H Scudamore; Eric M Yoshida; Alison C Harris; Kristin DeGirolamo; Stephen W Chung
Journal:  HPB (Oxford)       Date:  2013-02-01       Impact factor: 3.647

5.  Increased incidence of endoscopic erosive esophagitis in solid organ transplant recipients.

Authors:  In Soo Kim; Hyuk Lee; Jun Chul Park; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee
Journal:  Gut Liver       Date:  2012-07-12       Impact factor: 4.519

6.  High prevalence of reflux esophagitis among upper endoscopies in Chinese patients with chronic liver diseases.

Authors:  Bing Li; Bin Zhang; Jun Wei Ma; Peng Li; Lei Li; Yun Ming Song; Hui Guo Ding
Journal:  BMC Gastroenterol       Date:  2010-06-04       Impact factor: 3.067

Review 7.  Avoiding pitfalls: what an endoscopist should know in liver transplantation--part II.

Authors:  Sharad Sharma; Ahmet Gurakar; Cemalettin Camci; Nicolas Jabbour
Journal:  Dig Dis Sci       Date:  2008-12-17       Impact factor: 3.199

Review 8.  Epidemiology and clinical characteristics of GERD in the Japanese population.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-04-14       Impact factor: 7.527

Review 9.  Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practice.

Authors:  Rafael F Perini; Paula R S Camara; Jose G P Ferraz
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-02-03

10.  The Utilization and Diagnostic Yield of Upper Endoscopy for Evaluation of Gastrointestinal Symptoms Within the First Year After Liver Transplantation.

Authors:  Ebubekir Daglilar; Sean E Connolly; Veysel Tahan; Ari Cohen; George Therapondos
Journal:  Cureus       Date:  2020-11-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.